Synchron pauses trials of Stentrode brain implant over lead performance issue
Synchron pauses trials of its endovascular Stentrode brain implant over a lead problem; the FDA rejects Summit's ivonescimab in EGFR-mutated lung cancer and flu season arrives early with H1N1 dominant.